Psilera Selects bvFTD as Lead Indication for Clinical Testing of Psychedelic Derivative

January 25, 2024

Cybin Reports Positive Top-Line Results for Deuterated DMT Molecules

January 10, 2024

MAPS PBC Rebrands as Lykos Therapeutics

January 5, 2024

Silo Pharma Gets Green Light to Start Development of Ketamine Implant for Pain Relief

December 29, 2023

Kentucky Ibogaine Project in Limbo After State Opioid Commission Chair Resigns

December 28, 2023

MindBio Therapeutics Reports Progress on LSD Trial for Depression

December 21, 2023